|
|
|
Volumn 24, Issue 5, 1997, Pages 572-579
|
|
Chemotherapy for advanced sarcoma: Therapeutic decisions and modalities
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE DERIVATIVE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
DACARBAZINE;
DACTINOMYCIN;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
EPIRUBICIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
METHOTREXATE;
PACLITAXEL;
TOPOTECAN;
VINCRISTINE;
ADVANCED CANCER;
AGING;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESISTANCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
METASTASIS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SOFT TISSUE SARCOMA;
UTERUS SARCOMA;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
SARCOMA;
|
|
EID: 0030847431
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (59)
|
|
References (68)
|
